▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Henry Schein Q1 22 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 5/3/2022 9:00 AM ET

Henry Schein Inc. (HSIC) will host a conference call at 10:00 AM ET on May 3, 2022, to discuss Q1 22 earnings results.

To access the live webcast, log on to https://investor.henryschein.com/presentations?c=74322&p=irol-presentations

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

U.S. Reports 167K New Covid Cases, 625 Deaths

U.S. Reports 147K New Covid Cases, 397 Deaths

U.S. Reports 239K New Covid Cases, 934 Deaths

Fall In U.S. Covid Cases After Several Weeks

Biden Returning To Normal; Completes Paxlovid Course

Read More

COVID-19: Drugs in Development

RELATED NEWS

Henry Schein Q2 22 Earnings Conference Call At 10:00 AM ET

Henry Schein Lowers 2022 Sales Growth Outlook; Announces Restructuring Plan

Henry Schein Inc. Q2 Profit Increases, Inline With Estimates

Henry Schein To Buy Condor Dental Research For Undisclosed Financial Terms

Follow RTT

Editor's Pick
Most Read
Most Emailed

Deutsche Post DHL Q2 Profit Climbs, Backs FY22 View; Stock Up

Alibaba Q1 Profit Halves

Lufthansa Posts Profit In Q2, Updates FY22 EBIT View; Stock Up

Walmart Lays Off About 200 Corporate Employees

Moderna Q2 Results Top Estimates

Sangter Energy Supplement Recalled For Undeclared Sildenafil

BMW Stock Dips On Weak Q2 Profit, Delivery Outlook Revision

H-E-B Recalls Certain Creamy Creations Light Ice Cream

FTC Fines Opendoor Labs $62 Mln For Misleading Claims

Uber Posts Q2 Loss, Adj. EBITDA Improves; Sees Sequentially Higher Adj. EBITDA In Q3

BP Q2 Profit Climbs, Tops Estimates; Lifts Dividend, Plans Buyback; Stock Up

FTC Fines Opendoor Labs $62 Mln For Misleading Claims

DeWALT Recalls Nearly 1.4 Mln Miter Saws

Tesla Board Approves Three-for-One Stock Split

Alibaba Q1 Profit Halves

Amgen To Buy TAVNEOS Developer ChemoCentryx In $3.7 Bln Cash Deal

Lufthansa Posts Profit In Q2, Updates FY22 EBIT View; Stock Up

Uber Posts Q2 Loss, Adj. EBITDA Improves; Sees Sequentially Higher Adj. EBITDA In Q3

Sangter Energy Supplement Recalled For Undeclared Sildenafil

Molson Coors Beverage Falls On Lower Q2 Sales Below View

Allegan Aesthetics Of AbbVie Gets FDA Approval For Juvederm Volux XC For Jawline Treatment

AstraZeneca : EU Approves Lynparza For Early Breast Cancer

Remgro Reaches Agreement On Terms Of Acquisition Of Mediclinic

Amended: Eaton Q2 Net Profit Increases, Beats Estimates; Raises FY22 Outlook - Update

Alibaba Q1 Profit Halves

Fidelity European Trust H1 Net Return On Ordinary Activities Before Tax Rises On Revenue Basis

AES Maintains FY22 Adj. Earnings View - Update

Interface Q2 Profit Increases, Beats Estimates - Update

Bouygues HY Profit Drops

Illinois Tool Works Maintains FY22 Outlook - Update

Kratos Defense & Security Solutions, Inc. Q2 Earnings Summary

Sun Life Financial Inc. Q2 Profit Falls

Uber Slips To Loss In Q2, Revenues Surge; Issues Q3 Adj. EBITDA View - Quick Facts

Gibraltar Industries Q2 Profit Rises, Tops Estimates; Backs FY22 View

ITT Q2 Profit Increases, Beats Street; Updates 2022 Earnings Guidance - Update